Bioart Intellectual Property Disputes, Biotech Industry-Academia Partnerships & Regenerative Medicine Reimbursement: A Comprehensive Guide for Stakeholders
78% of bioartists face unresolved IP disputes (WIPO 2023), while 65% of biotech industry-academia partnerships fail due to IP conflicts